Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Assist Reprod Genet. 2012 Feb;29(2):105-15. doi: 10.1007/s10815-011-9694-6. Epub 2012 Jan 6.

The dynamics of the vaginal microbiome during infertility therapy with in vitro fertilization-embryo transfer.

Author information

  • 1Department of Biochemistry, Stanford University, Stanford, CA, USA.

Abstract

PURPOSE:

To determine the vaginal microbiome in women undergoing IVF-ET and investigate correlations with clinical outcomes.

METHODS:

Thirty patients had blood drawn for estradiol (E(2)) and progesterone (P(4)) at four time points during the IVF-ET cycle and at 4-6 weeks of gestation, if pregnant. Vaginal swabs were obtained in different hormonal milieu, and the vaginal microbiome determined by deep sequencing of the 16S ribosomal RNA gene.

RESULTS:

The vaginal microbiome underwent a transition during therapy in some but not all patients. Novel bacteria were found in 33% of women tested during the treatment cycle, but not at 6-8 weeks of gestation. Diversity of species varied across different hormonal milieu, and on the day of embryo transfer correlated with outcome (live birth/no live birth). The species diversity index distinguished women who had a live birth from those who did not.

CONCLUSIONS:

This metagenomics approach has enabled discovery of novel, previously unidentified bacterial species in the human vagina in different hormonal milieu and supports a shift in the vaginal microbiome during IVF-ET therapy using standard protocols. Furthermore, the data suggest that the vaginal microbiome on the day of embryo transfer affects pregnancy outcome.

PMID:
22222853
[PubMed - indexed for MEDLINE]
PMCID:
PMC3270134
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer Icon for PubMed Central
    Loading ...
    Write to the Help Desk